Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

JAK Inhibitors for Refractory Non-Infectious Ocular Inflammation: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Optimal Positioning.

PURPOSE Janus kinase (JAK) inhibitors have entered clinical testing for non-infectious ocular inflammation, but trial evidence is unsynthesized. We evaluated efficacy and safety within a pre-specified tiered framework. METHODS We searched five databases, three registries, and grey literature to July 4, 2026. Eligible...

I. M. U. Baytaroğlu, A. Baytaroğlu, Şerife Nur Çi̇ftci̇ et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.